Biomarker-Guided Oncology Practice in Non–Small Cell Lung Cancer: Utilization Patterns, Turnaround Time, and Sector-Associated Access Barriers. J Precis Med Health Res. 2025;2(2):e20. doi:10.61919/p8kycn81